← Browse by Condition
Medical Condition

pr positive breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04886531 Phase 2
Recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Enrollment
30 pts
Location
United States
Sponsor
Ruth O'Regan
View Trial →